Technical and Regulatory Considerations for Designing Next-Generation Sequencing Controls and Standards for Optimal Quality and Performance: A Panel Discussion.
Presented by Russell Garlick PhD - CSO LGC Clinical Diagnostics SeraCare LIfe Sciences
Karen Gutekunst PhD - VP of Regulatory Affairs Illumina
Bob Daber PhD - President and CTO Genosity
Federico Goodsend PhD - Principal Regulatory Pathfinders LLC
Jinjie Hu PhD - Principal Consultant for Axteria BioMed